Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Yen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Chemical Communications (Cambridge, England)|March 24, 2015
Non-invasive, real-time reporting drug release in vitro and in vivoYanfeng Zhang, Qian Yin, Jonathan Yen, et al.
Disease Models & Mechanisms|July 6, 2022
Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurationsKaitly J Woodard, Phillip A Doerfler, Kalin D Mayberry, et al.
Stem Cells and Development|January 10, 2012
Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell linesChunlin Zou, Bin-Kuan Chou, Sarah N Dowey, et al.
Scientific Reports|November 4, 2018
TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem CellsJonathan Yen, Michael Fiorino, Yi Liu, et al.
Stem Cells (Dayton, Ohio)|March 5, 2010
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genesPrashant Mali, Bin-Kuan Chou, Jonathan Yen, et al.
Nature Biotechnology|April 15, 2020
Directed evolution of adenine base editors with increased activity and therapeutic applicationNicole M Gaudelli, Dieter K Lam, Holly A Rees, et al.
Nature Chemical Biology|February 14, 2017
Selective in vivo metabolic cell-labeling-mediated cancer targetingHua Wang, Ruibo Wang, Kaimin Cai, et al.
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Chemical Communications (Cambridge, England)|March 24, 2015
Non-invasive, real-time reporting drug release in vitro and in vivoYanfeng Zhang, Qian Yin, Jonathan Yen, et al.
Disease Models & Mechanisms|July 6, 2022
Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurationsKaitly J Woodard, Phillip A Doerfler, Kalin D Mayberry, et al.
Stem Cells and Development|January 10, 2012
Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell linesChunlin Zou, Bin-Kuan Chou, Sarah N Dowey, et al.
Scientific Reports|November 4, 2018
TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem CellsJonathan Yen, Michael Fiorino, Yi Liu, et al.
Stem Cells (Dayton, Ohio)|March 5, 2010
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genesPrashant Mali, Bin-Kuan Chou, Jonathan Yen, et al.
Nature Biotechnology|April 15, 2020
Directed evolution of adenine base editors with increased activity and therapeutic applicationNicole M Gaudelli, Dieter K Lam, Holly A Rees, et al.
Nature Chemical Biology|February 14, 2017
Selective in vivo metabolic cell-labeling-mediated cancer targetingHua Wang, Ruibo Wang, Kaimin Cai, et al.
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.
Pageof 2